These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 18811243)

  • 1. Cord blood-derived neurons are originated from CD133+/CD34 stem/progenitor cells in a cell-to-cell contact dependent manner.
    Zangiacomi V; Balon N; Maddens S; Lapierre V; Tiberghien P; Schlichter R; Versaux-Botteri C; Deschaseaux F
    Stem Cells Dev; 2008 Oct; 17(5):1005-16. PubMed ID: 18811243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD133 allows elaborated discrimination and quantification of haematopoietic progenitor subsets in human haematopoietic stem cell transplants.
    Radtke S; Görgens A; Kordelas L; Schmidt M; Kimmig KR; Köninger A; Horn PA; Giebel B
    Br J Haematol; 2015 Jun; 169(6):868-78. PubMed ID: 25819405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human fetal hepatic progenitor cells are distinct from, but closely related to, hematopoietic stem/progenitor cells.
    Chen Q; Khoury M; Limmon G; Choolani M; Chan JK; Chen J
    Stem Cells; 2013 Jun; 31(6):1160-9. PubMed ID: 23404852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human cord blood-derived hematopoietic and neural-like stem/progenitor cells are attracted by the neurotransmitter GABA.
    Zangiacomi V; Balon N; Maddens S; Tiberghien P; Versaux-Botteri C; Deschaseaux F
    Stem Cells Dev; 2009 Nov; 18(9):1369-78. PubMed ID: 19327013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of CFU-GM, BFU-E and endothelial progenitor cells using ex vivo expansion of selected cord blood CD133(+) and CD34(+) cells.
    Lu X; Baudouin SV; Gillespie JI; Anderson JJ; Dickinson AM
    Cytotherapy; 2007; 9(3):292-300. PubMed ID: 17464761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro functional comparison of therapeutically relevant human vasculogenic progenitor cells used for cardiac cell therapy.
    Zhang Y; Wong S; Laflèche J; Crowe S; Mesana TG; Suuronen EJ; Ruel M
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):216-24, 224.e1-4. PubMed ID: 20167338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors.
    Timmermans F; Van Hauwermeiren F; De Smedt M; Raedt R; Plasschaert F; De Buyzere ML; Gillebert TC; Plum J; Vandekerckhove B
    Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1572-9. PubMed ID: 17495235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cord blood CD133 cells define an OV6-positive population that can be differentiated in vitro into engraftable bipotent hepatic progenitors.
    Crema A; Ledda M; De Carlo F; Fioretti D; Rinaldi M; Marchese R; Sanchez M; Giuliani M; Arena V; Durrbach A; Brunetti E; Haas C; Ponzetto A; Lisi A; Carloni G
    Stem Cells Dev; 2011 Nov; 20(11):2009-21. PubMed ID: 21291316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro identification of a cord blood CD133+CD34-Lin+ cell subset that gives rise to myeloid dendritic precursors.
    Goussetis E; Theodosaki M; Paterakis G; Tsecoura C; Graphakos S
    Stem Cells; 2006 Apr; 24(4):1137-40. PubMed ID: 16339995
    [No Abstract]   [Full Text] [Related]  

  • 10. Are purified or expanded cord blood-derived CD133+ cells better at improving cardiac function?
    Senegaglia AC; Barboza LA; Dallagiovanna B; Aita CA; Hansen P; Rebelatto CL; Aguiar AM; Miyague NI; Shigunov P; Barchiki F; Correa A; Olandoski M; Krieger MA; Brofman PR
    Exp Biol Med (Maywood); 2010 Jan; 235(1):119-29. PubMed ID: 20404026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuronal hypoxia in vitro: investigation of therapeutic principles of HUCB-MNC and CD133+ stem cells.
    Reich DM; Hau S; Stahl T; Scholz M; Naumann W; Emmrich F; Boltze J; Kamprad M
    BMC Neurosci; 2008 Sep; 9():91. PubMed ID: 18803816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of four methods for processing human cord blood and subsequent study of the expansion of progenitor stem cells isolated using the best method.
    Singh K; Srivastava A; Mathur N; Kumar S; Kumar L; Mukhopadhyay A; Konchupillai V
    Cytotherapy; 2009; 11(6):768-77. PubMed ID: 19878063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of differentiation and gene expression of CD133+ cells in human umbilical cord blood induced by SCF and bFGF].
    Zhang J; Zhu JS; Li QR; DU Y; Yang B; Li GX; Hu X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):146-50. PubMed ID: 20137136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-clinical development of cord blood-derived progenitor cell graft expanded ex vivo with cytokines and the polyamine copper chelator tetraethylenepentamine.
    Peled T; Mandel J; Goudsmid RN; Landor C; Hasson N; Harati D; Austin M; Hasson A; Fibach E; Shpall EJ; Nagler A
    Cytotherapy; 2004; 6(4):344-55. PubMed ID: 16146887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal analysis reveals a common progenitor for endothelial, myeloid, and lymphoid precursors in umbilical cord blood.
    Ramos AL; Darabi R; Akbarloo N; Borges L; Catanese J; Dineen SP; Brekken RA; Perlingeiro RC
    Circ Res; 2010 Dec; 107(12):1460-9. PubMed ID: 20947832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential gene expression profiling of CD34+ CD133+ umbilical cord blood hematopoietic stem progenitor cells.
    He X; Gonzalez V; Tsang A; Thompson J; Tsang TC; Harris DT
    Stem Cells Dev; 2005 Apr; 14(2):188-98. PubMed ID: 15910245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cells from cord blood CD133+CD34+ progenitors share phenotypic, functional and gene expression profile similarities with lymphatics.
    Nguyen VA; Fürhapter C; Obexer P; Stössel H; Romani N; Sepp N
    J Cell Mol Med; 2009 Mar; 13(3):522-34. PubMed ID: 18410526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of transcription factor Oct-4 and other embryonic genes in CD133 positive cells from human umbilical cord blood.
    Baal N; Reisinger K; Jahr H; Bohle RM; Liang O; Münstedt K; Rao CV; Preissner KT; Zygmunt MT
    Thromb Haemost; 2004 Oct; 92(4):767-75. PubMed ID: 15467907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of hyaluronan synthase genes in umbilical cord blood stem/progenitor cells.
    Grskovic B; Pollaschek C; Mueller MM; Stuhlmeier KM
    Biochim Biophys Acta; 2006 Jun; 1760(6):890-5. PubMed ID: 16564133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Purification, identification and oriented differentiation of endothelial progenitor cells from human umbilical cord blood].
    Xie ST; Chen B; Tao K
    Zhonghua Shao Shang Za Zhi; 2006 Oct; 22(5):355-8. PubMed ID: 17283881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.